Patients with CML had markedly increased (p<0.0001) levels of IL-6 compared to control individuals, indicating that IL-6 may have a role in the onset or progression of CML, as shown in Table 1 and Figure 1D. The gene discussed is IL6; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.